Literature DB >> 15842374

Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations.

L A O'Brien, J J Sutherland, D F Weaver, D Lillicrap.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15842374     DOI： 10.1111/j.1538-7836.2005.01219.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

Review 1.  von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.

Authors:  Paula D James; David Lillicrap
Journal:  Am J Hematol       Date:  2012-03-03       Impact factor: 10.047

Review 2.  Diagnosing von Willebrand disease: genetic analysis.

Authors:  Anne Goodeve
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Mechanistic studies on ADAMTS13 catalysis.

Authors:  Enrico Di Stasio; Stefano Lancellotti; Flora Peyvandi; Roberta Palla; Pier Mannuccio Mannucci; Raimondo De Cristofaro
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

Review 4.  The molecular genetics of von Willebrand disease.

Authors:  Ergül Berber
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

Review 5.  Of von Willebrand factor and platelets.

Authors:  Marijke Bryckaert; Jean-Philippe Rosa; Cécile V Denis; Peter J Lenting
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

6.  A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

Authors:  Christopher J Lynch; Adam D Cawte; Carolyn M Millar; David Rueda; David A Lane
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.